Ever Supreme Bio Technology Co., Ltd (6712.TWO)
TWD 171.5
(-0.29%)
TWD 171.5
(-0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 421.74 Million | 319.2 Million | 135.68 Million | -138.47 Million | -121.42 Million |
| Net Income | 623.01 Million | 264.1 Million | 396.82 Million | -137.39 Million | -94.21 Million |
| Depreciation & Amortization | 32.3 Million | 35.54 Million | 35.82 Million | 31.92 Million | 16.51 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 793 Thousand | 2.14 Million | 4.21 Million | 8.8 Million |
| Change in working capital | 28.3 Million | 27.39 Million | -26.14 Million | -23.12 Million | -20.88 Million |
| Other non-cash items | -14.14 Million | -9.37 Million | -2.78 Million | -2.86 Million | -31.63 Million |
| Investing Cash Flow | 61.59 Million | -287.3 Million | -296.82 Million | 146.76 Million | 140.63 Million |
| Investments in PPE | -5.83 Million | -5.59 Million | -4.65 Million | -60.81 Million | -5.36 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -116.7 Million | -301.59 Million | -541.7 Million | - | -54 Million |
| Sales/Maturities of investments | 181 Million | 22.4 Million | 225.49 Million | 216 Million | 222 Million |
| Other Investing Activities | 3.12 Million | -2.51 Million | -4.06 Million | -8.5 Million | 145.99 Million |
| Financing Cash Flow | -500.47 Million | -319.42 Million | 733.36 Million | 28.59 Million | -738 Thousand |
| Debt repayment | -11.92 Million | - | - | - | -3.72 Million |
| Dividends payments | -136.28 Million | -309.49 Million | - | - | - |
| Common Stock Repurchased | -356.35 Million | - | - | - | - |
| Common Stock Issuance | 3.93 Million | 2.36 Million | 744.93 Million | 37.45 Million | - |
| Other Financing Activities | 161 Thousand | -1.19 Million | -1.55 Million | 92 Thousand | 2.98 Million |
| Accounts receivables | -15.07 Million | - | - | - | -5.35 Million |
| Accounts payables | -5.74 Million | - | - | - | 1.15 Million |
| Inventory | 19.21 Million | -31.53 Million | -21.28 Million | -20.72 Million | -14.76 Million |
| Other working capital | 24.16 Million | - | - | - | -6.12 Million |
| Cash at beginning of period | 353.57 Million | 641.1 Million | 68.88 Million | 31.99 Million | 13.52 Million |
| Cash at end of period | 336.44 Million | 353.57 Million | 641.1 Million | 68.88 Million | 31.99 Million |
| Capital Expenditure | -5.83 Million | -5.59 Million | -4.65 Million | -60.81 Million | -5.36 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -17.13 Million | -287.53 Million | 572.22 Million | 36.88 Million | 18.47 Million |
| Free Cash Flow | 415.9 Million | 313.6 Million | 131.03 Million | -199.29 Million | -126.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 131.49 Million | 37.68 Million | 623.01 Million | 127.01 Million | 306.4 Million | 68.68 Million |
| Depreciation & Amortization | 7.59 Million | 7.63 Million | 32.3 Million | 7.68 Million | 7.64 Million | 7.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.03 Million | -15.3 Million | 28.3 Million | 45.23 Million | -42.91 Million | -36.47 Million |
| Other non-cash items | -2.72 Million | 18.75 Million | -14.14 Million | -1.01 Million | -1.41 Million | -8.76 Million |
| Investing Cash Flow | -288.87 Million | 519 Million | 61.59 Million | -164.2 Million | -304.03 Million | 62.58 Million |
| Investments in PPE | -783 Thousand | - | -5.83 Million | -1.31 Million | -1.1 Million | -3.26 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -341.16 Million | - | -116.7 Million | -82.6 Million | - | -34.09 Million |
| Sales/Maturities of investments | 95.1 Million | 519 Million | 181 Million | -82.39 Million | -303.99 Million | 100 Million |
| Other Investing Activities | -288.09 Million | - | 3.12 Million | 2.11 Million | 1.06 Million | - |
| Financing Cash Flow | -442.84 Million | -2.95 Million | -500.47 Million | -2.9 Million | -359.2 Million | -135.38 Million |
| Debt repayment | -2.93 Million | - | - | - | - | - |
| Dividends payments | -440.03 Million | - | -136.28 Million | - | - | - |
| Common Stock Repurchased | - | - | -356.35 Million | - | - | - |
| Common Stock Issuance | - | - | 3.93 Million | - | - | 3.93 Million |
| Other Financing Activities | 130 Thousand | - | 161 Thousand | 102 Thousand | - | - |
| Accounts receivables | -47.9 Million | - | - | - | - | - |
| Accounts payables | 7.15 Million | - | - | - | - | - |
| Inventory | -12.68 Million | -22.76 Million | 19.21 Million | 7.57 Million | 5.78 Million | 2.81 Million |
| Other working capital | 42.89 Million | - | - | - | - | - |
| Cash at beginning of period | 943.48 Million | 336.44 Million | 353.57 Million | 312.64 Million | 890.21 Million | 912.96 Million |
| Cash at end of period | 265.27 Million | 943.48 Million | 336.44 Million | 336.44 Million | 312.64 Million | 890.21 Million |
| Capital Expenditure | -783 Thousand | - | -5.83 Million | -1.31 Million | -1.1 Million | -3.26 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -678.2 Million | 607.04 Million | -17.13 Million | 23.79 Million | -577.56 Million | -22.75 Million |
| Free Cash Flow | 52.72 Million | 90.99 Million | 415.9 Million | 189.58 Million | 84.57 Million | 46.77 Million |
6971
SHARDAMOTR
9444
688670
2001
4180